Eucrates Biomedical Acquisition Corp.
Hedge Funds Holdings

Last updated:

Eucrates Biomedical Acquisition Corp.‘s stocks are currently a part of 5 hedge funds’ portfolios, which represents 7.04% of the total amount of its stocks outstanding. This makes up a total of 296.51K shares of Eucrates Biomedical Acquisition Corp.. Compared to the previous quarter, the number fell by -82.10% or -1.36M shares fewer. As for the holding position changes, 20% (1) of current hedge fund investors increased the number of shares held, and 100% (5) closed the holdings completely. 2 hedge funds are new holders of Eucrates Biomedical Acquisition Corp. stock in Q1 2023, it is 40% of total holders.

Hedge funds holding Eucrates Biomedical Acquisition Corp. (Q1 2020 – Q1 2023)

Number of hedge funds
Q1 2020 1
Q3 2020 0
Q4 2020 3
Q1 2021 15
Q2 2021 19
Q3 2021 17
Q4 2021 19
Q1 2022 20
Q2 2022 22
Q3 2022 21
Q4 2022 24
Q1 2023 5

Hedge funds changes in Eucrates Biomedical Acquisition Corp. positions (Q1 2020 – Q1 2023)

Changes in positions
Q1 2020 10000
Q3 2020 0001-1
Q4 2020 30000
Q1 2021 130011
Q2 2021 52219
Q3 2021 112310
Q4 2021 412210
Q1 2022 42239
Q2 2022 52339
Q3 2022 016113
Q4 2022 63339
Q1 2023 2105-3

Hedge funds changes in Eucrates Biomedical Acquisition Corp. stock options (Q1 2020 – Q1 2023)

Changes in stock options
Q1 2020 0 0
Q3 2020 0 0
Q4 2020 335,000 0
Q1 2021 0 0
Q2 2021 0 0
Q3 2021 0 0
Q4 2021 0 0
Q1 2022 661,000 0
Q2 2022 2,000 0
Q3 2022 1,000 0
Q4 2022 1,000 0
Q1 2023 0 0